Newsroom | 26632 results

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), the global leader in glucose biosensing, announced today through ongoing quality and accounting reviews it recently identified certain lots of Dexcom G7 sensors originally designated as scrap and intended for destruction were stolen during the destruction process, then sold by third parties. Scrapping limited amounts of sensors that do not meet Dexcom standards is a routine part of the company’s quality control process. Sensors identified...

SAN FRANCISCO--(BUSINESS WIRE)--Solace is featured in the "Age Reimagined" series presented by the Global Coalition on Aging and produced by BBC StoryWorks Commercial Productions....

BERKELEY, Calif.--(BUSINESS WIRE)--The dataset is now available to the research community to accelerate the development of improved models for protein stability prediction....

NEW YORK--(BUSINESS WIRE)--Peloton Interactive, Inc. (NASDAQ: PTON) today announced the appointment of Siddharth (“Sid”) Thacker as the company’s Chief Financial Officer, effective June 22, 2026. Thacker, an accomplished finance leader with a deep foundation as an institutional investor, will oversee Peloton’s global finance organization as well as corporate strategy. Under his leadership, Peloton will maintain its disciplined financial approach while pursuing broader market opportunities acros...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine is expected to join broad-market Russell 3000® Index & small-cap Russell 2000® Index at the conclusion of June 2026 Russell Reconstitution....

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of a new multi-attribute method (MAM) workflow designed to help pharmaceutical and biopharmaceutical quality control (QC) laboratories implement liquid chromatography high-resolution mass spectrometry (LC/HRMS) in routine, regulated testing environments. The Agilent MAM solution brings together software, instrumentation, columns, consumables and standards to address practical and operational ba...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--ViaLase announced the successful completion of the first commercial FLIGHT procedures, marking a new era in interventional glaucoma....

NEW YORK--(BUSINESS WIRE)--Swoop today announced the acquisition of Nimble, a leading prescription management platform....

WASHINGTON--(BUSINESS WIRE)--Curi Bio, a global leader in functional human biology, today unveiled the Curiverse™ at the Microphysiological Systems World Summit (MPS) 2026, the industry’s first closed-loop ecosystem unifying assay-ready iPSC-derived cells, automated high-throughput systems, and cloud-based data analytics for industrial-scale 3D human drug discovery. The launch consolidates Curi Bio’s H1 2026 portfolio under a single integrated architecture purpose-built for pharma and biotech s...

中国北京--(BUSINESS WIRE)--(美国商业资讯)-- 百奥赛图（北京）医药科技股份有限公司（以下简称“百奥赛图”，SSE: 688796；HKEX: 02315），近日宣布正式发布 RenSuper Workstation，这一新一代 AI 驱动的抗体发现平台，面向全球合作伙伴提供可现货获取的大规模、经实验验证的全人源治疗性抗体资源，支持推动抗体发现从“定制化项目”迈向“可检索、可规模化、更高效”的新模式。 平台崛起的底座：真实全人抗体库 + AI与自动化双引擎 RenSuper Workstation的核心基础，来自百奥赛图依托自主RenMice®全人抗体小鼠平台长期积累的规模化免疫与真实数据体系。 围绕1000+潜在可成药靶点，百奥赛图开展大规模体内免疫与筛选，构建了海量真实全人抗体序列“现货分子库”。这一“真实库”与传统依赖预测模型生成的虚拟库不同，其每条序列均来源于体内免疫并经过实验验证，具备真实结合与功能证据，为抗体研发提供更可靠的源头分子资产。 在此基础上，RenSuper将大规模体内免疫、下一代测序（NGS）、AI驱动的高通量筛选、实验验证整合为统一工作流，...